TransCode is a Massachusetts-based biopharmaceutical company that develops and discovers RNA interference therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 2-10
Address: 6 Liberty Square
City: Boston
State: MA
Zip: 02109
Country: US
TransCode is a Massachusetts-based biopharmaceutical company that develops and discovers RNA interference therapeutics for the treatment of cancer.
Contact Phone:
+18573016857
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/8/2021
IPO Valuation:
$48M
Ticker Symbol:
RNAZ
IPO Price:
$4/share
Amount Raised:
$25M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Post-IPO Equity | 1 | - |
Red Cedar Ventures Red Cedar Ventures |
6/2022 | Grant | 1 | $1.1M |
National Cancer Institute National Cancer Institute |
8/2014 | Seed Round | 1 | - |
Red Cedar Ventures Red Cedar Ventures |
8/2021 | Grant | 1 | - |
National Institutes of Health National Institutes of Health |
8/2021 | Grant | $2.3M |
NIH |
7/2021 | IPO | $25M | 8/2021 | Grant | 1 | - |
National Institutes of Health National Institutes of Health |
8/2014 | Seed Round | 1 | - |
Red Cedar Ventures Red Cedar Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|